Applied Therapeutics Inc (APLT)
9.625
+0.36
(+3.83%)
USD |
NASDAQ |
Nov 22, 16:00
9.39
-0.24
(-2.44%)
After-Hours: 20:00
Applied Therapeutics Cash from Operations (Quarterly): -23.33M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -23.33M |
| June 30, 2024 | -22.60M |
| March 31, 2024 | -18.91M |
| December 31, 2023 | -17.00M |
| September 30, 2023 | -14.73M |
| June 30, 2023 | -16.45M |
| March 31, 2023 | -6.99M |
| December 31, 2022 | -15.89M |
| September 30, 2022 | -19.39M |
| June 30, 2022 | -18.40M |
| March 31, 2022 | -24.41M |
| December 31, 2021 | -26.94M |
| September 30, 2021 | -15.66M |
| June 30, 2021 | -25.91M |
| Date | Value |
|---|---|
| March 31, 2021 | -22.21M |
| December 31, 2020 | -22.75M |
| September 30, 2020 | -20.69M |
| June 30, 2020 | -15.91M |
| March 31, 2020 | -18.86M |
| December 31, 2019 | -12.41M |
| September 30, 2019 | -7.839M |
| June 30, 2019 | -9.059M |
| March 31, 2019 | -7.002M |
| December 31, 2018 | -5.869M |
| September 30, 2018 | -2.02M |
| June 30, 2018 | -2.162M |
| March 31, 2018 | -1.131M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-26.94M
Minimum
Dec 2021
-6.99M
Maximum
Mar 2023
-18.97M
Average
-18.88M
Median
Cash from Operations (Quarterly) Benchmarks
| ResMed Inc | 325.54M |
| Axonics Inc | 0.922M |
| Organon & Co | 141.00M |
| NovaBay Pharmaceuticals Inc | -2.061M |
| Palatin Technologies Inc | -7.016M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -81.84M |
| Free Cash Flow Per Share (Quarterly) | -0.1616 |
| Free Cash Flow to Equity (Quarterly) | -23.33M |
| Free Cash Flow Yield | -6.39% |